Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon Events
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsMedicilon Events

Medicilon Events

Hot information：
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division| Medicilon and Wuhan biolake successfully organized a biopharmaceutical salon| Medicilon FTE services & FFS services - flexible and efficient cooperation model
Jun 30,2020
Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research
Chuansha, Shanghai, June 29, 2020. — Convalife and Medicilon signed a strategic pact, initiating a long-term cooperation between the two companies. Based on previous cooperation
More
Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research
Jun 15,2020
Medicilon will participate 2020 SAPA Healthcare Investment Forum & Roadshow
Due to the COVID-19 pandemic, the 2020 SAPA Healthcare Investment Forum & Roadshow will be divided in 2 parts.  Part I will be hosted as
More
Medicilon will participate 2020 SAPA Healthcare Investment Forum & Roadshow
Jun 04,2020
Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308
Congratualtions to Medicilon's partner, Bio-Thera, on obtaining NMPA's approval of clinical trials of BAT1308. On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of
More
Congratualtions to Bio-Thera on obtaining NMPA’s approval of clinical trials of BAT1308
Jun 01,2020
Medicilon received the "Most Improved in the Science and Technology” award
Led by Dr. CHUN-LIN CHEN, the founder and CEO of Shanghai Medicilon Inc., the entreprenuer team in Medicilon received the "Most Improved in the Science and Technology” award presented by Pudong New Area.
More
Medicilon received the "Most Improved in the Science and Technology” award
Apr 22,2020
Medicilon Preclinical Research-Mouse Tumor Model
As the incidence and mortality of cancer have increased year by year, cancer has become the primary enemy threatening human health. Therefore, more and more
More
Medicilon Preclinical Research-Mouse Tumor Model
Apr 21,2020
Formulation Research of Innovative Drugs
Zhangjiang Runhe International Office Garden Opened On April 15, 2020, the opening ceremony of Zhangjiang Runhe International Office Garden was successfully held.  The Member of
More
Formulation Research of Innovative Drugs
Apr 17,2020
Medicilon entered Zhangjiang Runhe International Office Garden as the first batch of contracted enterprises
Malignant tumors, Alzheimer's disease, diabetes, rheumatoid arthritis… These intractable diseases that threaten human health have long plagued us, bringing pain and suffering to unfortunate patients,
More
Medicilon entered Zhangjiang Runhe International Office Garden as the first batch of contracted enterprises
Apr 01,2020
Medicilon CMC-Formulation Department
In 2019, Medicilon has had an extraordinary year. The steadily developing Medicilon made a huge accumulation in 2019 and achieved a qualitative leap.  Let us
More
Medicilon CMC-Formulation Department
Mar 11,2020
Medicilon Drug Discovery - Chemistry Department
The Medicilon Chemistry Department is a professional, efficient, and well-qualified R&D team. The team has more than 40% of employees with a master's degree, doctor's degree, or above.
More
Medicilon Drug Discovery - Chemistry Department
Mar 10,2020
API Process Development of the New Drug IND Stage
In the development of innovative drugs, the progress of the process development of the IND phase of the API often directly affects the subsequent formulation
More
API Process Development of the New Drug IND Stage
Feb 02,2020
Taking the Responsibility and Praying for the Peace; Medicilon helps to fight the coronavirus by providing funds and technology
During the Spring Festival, China has been facing a difficult time as the coronavirus spread all over the country.  In order to stop the coronavirus,
More
Taking the Responsibility and Praying for the Peace; Medicilon helps to fight the coronavirus by providing funds and technology
Dec 27,2019
Medicilon Assists Neupharma's RX108 to Enter Phase I Clinical Trials
​Recently, Suzhou Neupharma, an important partner of Shanghai Medicilon, announced that RX208 China phase I clinical research has completed the administration of the first patient in Shanghai Dongfang Hispital.
More
Medicilon Assists Neupharma's RX108 to Enter Phase I Clinical Trials
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->